Tema ETFs
SNDX icon

Tema ETFs’s Syndax Pharmaceuticals SNDX Stock Holding History

Tema ETFs’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$545K Sell
28,998
-43,214
-60% -$873K 0.02% 404
2026
Q2 		$1.58M Buy
72,212
+13,864
+24% +$288K 0.05% 216
2026
Q1 		$1.36M Sell
58,348
-41,705
-42% -$906K 0.09% 193
2025
Q4 		$2.1M Sell
100,053
-10,013
-9% -$175K 0.16% 148
2025
Q3 		$1.69M Buy
110,066
+23,765
+28% +$311K 0.14% 182
2025
Q2 		$808K Buy
86,301
+65,132
+308% +$717K 0.21% 116
2025
Q1 		$260K Buy
+21,169
New +$299K 0.08% 135

Other funds holding SNDX

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Harbour Capital Advisors
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Post Resch Tallon Group
Post Resch Tallon Group Pittsford, New York $146M AUM 18.19% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
CIA
Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Tema ETFs's SNDX Position: Q3 2026 in Review

Tema ETFs reduced its Syndax Pharmaceuticals (SNDX) stake by 60% in Q3 2026, selling an estimated $873K and leaving 28,998 shares worth $545K. The position accounts for 0.02% of the portfolio, ranked #404.

Tema ETFs first reported a position in SNDX in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.1M in Q4 2025. 21 funds tracked by Wall St. Rank hold SNDX as of Q3 2026.

  • Tema ETFs held 28,998 shares of Syndax Pharmaceuticals worth $545K as of Q3 2026.
  • Tema ETFs sold 43,214 Syndax Pharmaceuticals shares in Q3 2026, an estimated $873K.
  • Syndax Pharmaceuticals made up 0.02% of Tema ETFs's portfolio in Q3 2026, its #404 holding.
  • Tema ETFs first reported a position in Syndax Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • Tema ETFs's Syndax Pharmaceuticals position peaked at $2.1M in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.